General Information |
| Organization Type - Primary: |
Academic / Research Institution |
| Organization Type - Secondary: |
None |
| Is your organization legally registered in your country: |
Yes |
| Organization Reach: |
National |
| Organization Description: |
CIDRZ TB Unit
Programs
TB Research: The TB Unit has developed an exceptional environment for clinical research and conducts ongoing operations and public health research focused on the diagnosis or treatment of tuberculosis, and to assess the impact and outcomes of programmatic interventions to continually improve our activities. Studies address TB-related issues in diverse populations including prisoners, pregnant women, and HIV-infected adults and children. The CIDRZ portfolio of TB implementation science and clinical research has increased substantially over the past five years to 3.4 million USD with six funded projects. These include trials on treatment strategies for TB/HIV co-infected adult and paediatric patients (ACTG 5221, ACTG 5274), TB screening studies under the CDC-Public Health Evaluation (PHE) mechanism (LED Fluorescence microscopy field evaluations & TB-HIV Cohort), special populations studies funded by NIH (TB in pregnancy and Vitamin D levels in HIV/TB patients), and a TB drug trial (ReMox) under Global Alliance for TB Drug Development. Other TB-related research activities include the development of a TB specimen repository for research on new diagnostics and biomarkers. Recently the TB team has been awarded a grant to implement a sustainable TB screening program for 11,000 Zambian prisoners under the TB REACH Initiative (Stop TB Partnership, WHO). Our research activities serve as a link between the public health and research communities and inform policy at the Ministry of Health level. We are involved in a consortium, that includes private/public north-south and south-south collaborations, in the area of digital x-ray computer-assisted TB diagnosis which is in the process of being established with the University of Nijmegen (Netherlands), University of Cape Town Lung Institute (South Africa) and Delft Imaging (Netherlands).
Laboratory Support
The TB laboratory is a regional reference facility with culture and molecular diagnostic capacity. It is co-located alongside a service and res |
| |
| Total number of staff in your organization: |
100 + |
| Number of full-time staff who are directly involved with TB: |
100 + |
| Number of part-time staff who are directly involved with TB: |
0 |
| Number of volunteers who are directly involved with TB: |
0 |
| |
| What is your organization's annual budget (USD) dedicated to TB? |
$1 MIL-$10 MIL |
| How did you hear about the Stop TB Partnership: |
Stop TB communications |
| Why do you wish join the Stop TB Partnership: |
Information on developments within the TB world |
| |
| Are you a member of a Stop TB national partnership: |
No |
| Are you in contact with your national TB programme: |
Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: |
TB Service:
The CIDRZ TB team works closely with the Zambian Ministry of Health and the National TB Program to improve the screening, diagnosis and management of TB in HIV-infected patients in Lusaka, Southern, Western, and Eastern provinces. This team has led the rapid scale-up of TB services in HIV-infected patients: After starting with one pilot site in late 2005, the team revamped the program and expanded support to three additional sites in 2006. By 2007, annual funding tripled to 3.8 million USD and in 2008 and 2009 we rapidly expanded throughout Lusaka, Western, and Southern provinces to 254 government health centers in 12 districts. As of 28th February, 2011 the CIDRZ TB program has trained over 1,242 health workers and is supporting provider initiated testing and counseling (PITC) programs and clinical mentoring in 23 Lusaka District health centers; 122 health centers in Southern province; 71 health centers in Western province and 43 health centers in Eastern province. Due to the team’s collective experience in implementing TB programs and their established relationships with the NTP and other TB partners in Zambia, it is in a strong position to implement future interventions of public health importance. |
| |
Geographical Reach |
| Which country is your headquarters located in: |
Zambia |
| Which WHO region is the main focus of your work: |
African |
Which countries do you do operate in:
(This includes countries you are conducting activities in) |
Zambia
|
